Moneycontrol PRO
Contest Alert:1 day left to win Amazon vouchers worth Rs 5000. Take the MCPRO Quiz today to grab yours!
you are here: HomeNewsIndia

India working on aggressive strategy to attract FDI: Suresh Prabhu

Prabhu in a virtual interaction with members of the Indo-Canadian Business Chamber (ICBC) recognized the impact of the COVID-19 pandemic and the changes it would bring to global business and trade practices, while outlining eight key areas of enhanced cooperation between India and Canada going forward, according to a statement.

May 05, 2020 / 08:53 PM IST

India's Sherpa for G20 and G7 groups Suresh Prabhu on Tuesday said the government is working on an aggressive strategy to attract FDI into India in the aftermath of COVID-19 pandemic.

Prabhu in a virtual interaction with members of the Indo-Canadian Business Chamber (ICBC) recognized the impact of the COVID-19 pandemic and the changes it would bring to global business and trade practices, while outlining eight key areas of enhanced cooperation between India and Canada going forward, according to a statement.

Coronavirus India News LIVE

He specifically listed out high-tech, financial services, capital investment, healthcare, manufacturing, environment, logistics and trade promotion as those that would see a major uptick between the two countries, the ICBC said in the statement.

Prabhu also pointed out that the Prime Minister has constituted a task force headed by the finance minister which is looking specifically into this and he is sure it will be communicated to the right people soon.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
Follow our full coverage of the coronavirus pandemic here.
PTI

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark